This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

3 Stocks Hit 52-Week Highs

Stocks in this article: CL ALGT AKRX

NEW YORK ( TheStreet) -- The following stocks hit 52-week highs on Tuesday: Colgate-Palmolive (CL - Get Report), Allegiant Travel (ALGT - Get Report) and Akorn (AKRX - Get Report).

Colgate-Palmolive

"We are raising our 12m PO to $110 from $106, based on an 18.5x forward P/E on our 2013 EPS estimates, following meetings with mgmt last week and incremental analysis of the competitive setting," Bank of America Merrill Lynch analysts wrote in a May 11 report. "CL is our top large cap pick. We believe 6%+ organic sales is sustainable in the medium-term, and EBIT growth and earnings quality are both likely to improve thru 2012, which should set CL apart from most of its Staples peers, offering potential for even higher relative valuation."

Shares of Colgate-Palmolive hit a 52-week high on Tuesday of $101.60. The stock's 52-week low of $78.62 was set on Aug. 9.

Colgate-Palmolive trades at an estimated price-to-earnings ratio for next year of 17.12 times; the average for personal products companies is 15.4. For comparison, Avon Products (AVP) has a lower forward P/E of 15.42.

Fifteen of the 25 analysts who cover Colgate-Palmolive rated it hold. Eight analysts gave the stock a buy rating and two rated it sell.

The stock has risen 9.99% year to date.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,434.19 -244.51 -1.38%
S&P 500 2,035.32 -21.77 -1.06%
NASDAQ 4,705.3560 -66.4070 -1.39%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs